{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:14:06Z","timestamp":1791389646897,"version":"4.3.3"},"reference-count":103,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.it.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:20:04Z","timestamp":1657585204000},"page":"657-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Type 2 immunity: a two-edged sword in schistosomiasis immunopathology"],"prefix":"10.1016","volume":"43","author":[{"given":"Nada","family":"Abdel Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fungai","family":"Musaigwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paballo","family":"Mosala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inssaf","family":"Berkiks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Brombacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2022.06.005_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.it.2022.06.005_bb0010","series-title":"Schistosomiasis","author":"WHO","year":"2018"},{"key":"10.1016\/j.it.2022.06.005_bb0015","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1038\/s41598-020-67514-4","article-title":"Investigating the antifibrotic effect of the antiparasitic drug praziquantel in in vitro and in vivo preclinical models","volume":"10","author":"Nono","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2022.06.005_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.curtheres.2019.06.001","article-title":"Schistosomiasis: life cycle, diagnosis, and control","volume":"91","author":"Nelwan","year":"2019","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.it.2022.06.005_bb0025","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1812165","article-title":"Schistosomiasis - assessing progress toward the 2020 and 2025 Global Goals","volume":"381","author":"Deol","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2022.06.005_bb0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"2","author":"Pearce","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41577-020-0301-x","article-title":"Heterogeneity in the initiation, development and function of type 2 immunity","volume":"20","author":"Gause","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0040","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3389\/fimmu.2020.01018","article-title":"Behind enemy lines: immunomodulatory armamentarium of the schistosome parasite","volume":"11","author":"Angeles","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-014-0608-1","article-title":"Sm16, a major component of Schistosoma mansoni cercarial excretory\/secretory products, prevents macrophage classical activation and delays antigen processing","volume":"8","author":"Sanin","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.it.2022.06.005_bb0050","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/IAI.01126-08","article-title":"The Schistosoma mansoni protein Sm16\/SmSLP\/SmSPO-1 assembles into a nine-subunit oligomer with potential to inhibit Toll-like receptor signaling","volume":"77","author":"Brannstrom","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.it.2022.06.005_bb0055","first-page":"13","article-title":"Secretion of an anti-inflammatory, immunomodulatory factor by schistosomulae of Schistosoma mansoni","volume":"46","author":"Ramaswamy","year":"1995","journal-title":"J. Inflamm."},{"key":"10.1016\/j.it.2022.06.005_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.624178","article-title":"Immune evasion strategies of schistosomes","volume":"11","author":"Hambrook","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0065","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4049\/jimmunol.168.5.2255","article-title":"Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions","volume":"168","author":"Harizi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0070","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3389\/fimmu.2019.01306","article-title":"Role of dendritic cells in natural immune control of HIV-1 infection","volume":"10","author":"Martin-Gayo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000667","article-title":"Functional impairment of human myeloid dendritic cells during Schistosoma haematobium infection","volume":"4","author":"Everts","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.it.2022.06.005_bb0080","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1084\/jem.20100734","article-title":"CD11c depletion severely disrupts Th2 induction and development in vivo","volume":"207","author":"Phythian-Adams","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2022.06.005_bb0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00281-012-0354-4","article-title":"Th2 responses in schistosomiasis","volume":"34","author":"Fairfax","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.it.2022.06.005_bb0090","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20111381","article-title":"Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor","volume":"209","author":"Everts","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2022.06.005_bb0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41337","article-title":"Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni","volume":"8","author":"Ittiprasert","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.it.2022.06.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005504","article-title":"Dectin-1\/2-induced autocrine PGE2 signaling licenses dendritic cells to prime Th2 responses","volume":"16","author":"Kaisar","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2022.06.005_bb0105","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.4049\/jimmunol.171.11.5837","article-title":"Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism","volume":"171","author":"Thomas","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0110","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.15252\/embj.201695345","article-title":"Type I interferon is required for T helper (Th) 2 induction by dendritic cells","volume":"36","author":"Webb","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.it.2022.06.005_bb0115","doi-asserted-by":"crossref","first-page":"15820","DOI":"10.1038\/ncomms15820","article-title":"Different populations of CD11b(+) dendritic cells drive Th2 responses in the small intestine and colon","volume":"8","author":"Mayer","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2022.06.005_bb0120","doi-asserted-by":"crossref","first-page":"592325","DOI":"10.3389\/fimmu.2020.592325","article-title":"Defined intestinal regions are drained by specific lymph nodes that mount distinct Th1 and Th2 Responses against Schistosoma mansoni eggs","volume":"11","author":"Mayer","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4049\/immunohorizons.2100071","article-title":"Plasmacytoid dendritic cells facilitate Th cell cytokine responses throughout Schistosoma mansoni infection","volume":"5","author":"Webb","year":"2021","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.it.2022.06.005_bb0130","first-page":"1","article-title":"House dust mite induced allergic airway disease is attenuated in CD11ccreIL-4R\u03b1\u2212\/l\u00b0 x mice","volume":"8","author":"Nieuwenhuizen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2022.06.005_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/JLB.MA0318-115R","article-title":"IL-4Ralpha-expressing CD11c(+) cells contribute to driving optimal cellular responses during Schistosoma mansoni infection in mice","volume":"105","author":"Ndlovu","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.it.2022.06.005_bb0140","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/356604a0","article-title":"Tumour necrosis factor \u03b1 restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice","volume":"356","author":"Amiri","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.it.2022.06.005_bb0145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/iai.54.3.820-826.1986","article-title":"Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection","volume":"54","author":"Mathew","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.it.2022.06.005_bb0150","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/eji.1830270518","article-title":"Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni","volume":"27","author":"Hernandez","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0155","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.4049\/jimmunol.1401155","article-title":"T cell-derived IL-4\/IL-13 protects mice against fatal Schistosoma mansoni infection independently of basophils","volume":"193","author":"Schwartz","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0160","first-page":"207","article-title":"Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes: II. Pathology and altered pathogenesis","volume":"71","author":"Buchanan","year":"1973","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2022.06.005_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fimmu.2020.00061","article-title":"T lymphocyte-mediated liver immunopathology of schistosomiasis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0170","first-page":"119","article-title":"Current understanding of immunity against schistosomiasis: impact on vaccine and drug development","volume":"11","author":"Molehin","year":"2020","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.it.2022.06.005_bb0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2172-11-56","article-title":"Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection","volume":"11","author":"de Oliveira Fraga","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.779534","article-title":"Association of IL-9, IL-10, and IL-17 cytokines with hepatic fibrosis in human Schistosoma mansoni infection","volume":"12","author":"Franco","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0185","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2567.2004.02083.x","article-title":"Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice","volume":"114","author":"Singh","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.it.2022.06.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005850","article-title":"The Foxp3+ regulatory T-cell population requires IL-4Ralpha signaling to control inflammation during helminth infections","volume":"16","author":"Abdel Aziz","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2022.06.005_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005861","article-title":"Host regulation of liver fibroproliferative pathology during experimental schistosomiasis via interleukin-4 receptor alpha","volume":"11","author":"Nono","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.it.2022.06.005_bb0200","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4269\/ajtmh.2007.77.676","article-title":"T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment","volume":"77","author":"Watanabe","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.it.2022.06.005_bb0205","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00436-022-07435-5","article-title":"Profile of T and B lymphocytes in individuals resistant to Schistosoma mansoni infection","volume":"121","author":"da Paix\u00e3o de Souza","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.it.2022.06.005_bb0210","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2353\/ajpath.2009.090137","article-title":"IL-4R\u03b1 responsiveness of non-CD4 T cells contributes to resistance in Schistosoma mansoni infection in pan-T cell-specific IL-4R\u03b1-deficient mice","volume":"175","author":"Dewals","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2022.06.005_bb0215","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4049\/jimmunol.169.2.906","article-title":"Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice","volume":"169","author":"Faveeuw","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0220","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.01178-06","article-title":"Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis","volume":"75","author":"Mallevaey","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.it.2022.06.005_bb0225","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.176.4.2476","article-title":"Activation of invariant NKT cells by the helminth parasite Schistosoma mansoni","volume":"176","author":"Mallevaey","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-3083.1998.00376.x","article-title":"Infection of B-cell-deficient mice by the parasite Schistosoma mansoni: demonstration of the participation of B cells in granuloma modulation","volume":"48","author":"Ferru","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0235","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.158.10.4832","article-title":"In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation","volume":"158","author":"Hernandez","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0240","doi-asserted-by":"crossref","first-page":"E8430","DOI":"10.1073\/pnas.1708125114","article-title":"IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases","volume":"114","author":"Hurdayal","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2022.06.005_bb0245","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.3389\/fimmu.2018.02928","article-title":"Interleukin-4 receptor alpha expressing B cells are essential to down-modulate host granulomatous inflammation during schistosomasis","volume":"9","author":"Ndlovu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030883","article-title":"Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells","volume":"7","author":"van der Vlugt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2022.06.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002490","article-title":"IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease","volume":"8","author":"Fairfax","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.06.005_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006539","article-title":"Schistosome egg antigens, including the glycoprotein IPSE\/alpha-1, trigger the development of regulatory B cells","volume":"13","author":"Haeberlein","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.06.005_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-020-04015-3","article-title":"B cells induced by Schistosoma japonicum infection display diverse regulatory phenotypes and modulate CD4+ T cell response","volume":"13","author":"Xiao","year":"2020","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.it.2022.06.005_bb0270","doi-asserted-by":"crossref","first-page":"e0005094","DOI":"10.1371\/journal.pntd.0005094","article-title":"Blockade of PD-1 signaling enhances Th2 cell responses and aggravates liver immunopathology in mice with schistosomiasis japonica","volume":"10","author":"Zhou","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.it.2022.06.005_bb0275","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-032712-095906","article-title":"Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease","volume":"31","author":"Van Dyken","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0280","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","article-title":"Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology","volume":"20","author":"Herbert","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.it.2022.06.005_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.06.005_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000393","article-title":"Retnla (relmalpha\/fizz1) suppresses helminth-induced Th2-type immunity","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.06.005_bb0295","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/eji.201141869","article-title":"Macrophage activation governs schistosomiasis-induced inflammation and fibrosis","volume":"41","author":"Barron","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0300","doi-asserted-by":"crossref","first-page":"2790627","DOI":"10.1155\/2018\/2790627","article-title":"Macrophage activation and functions during helminth infection: recent advances from the laboratory mouse","volume":"2018","author":"Rolot","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.it.2022.06.005_bb0305","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3389\/fmicb.2020.01973","article-title":"Monocyte and macrophage-mediated pathology and protective immunity during schistosomiasis","volume":"11","author":"Souza","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.it.2022.06.005_bb0310","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/eji.201847796","article-title":"Recruitment of hepatic macrophages from monocytes is independent of IL-4R\u03b1 but is associated with ablation of resident macrophages in schistosomiasis","volume":"49","author":"Rolot","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0315","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.immuni.2017.11.015","article-title":"Recent advances in type-2-cell-mediated immunity: insights from helminth infection","volume":"47","author":"Harris","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.it.2022.06.005_bb0320","doi-asserted-by":"crossref","first-page":"711907","DOI":"10.3389\/fimmu.2021.711907","article-title":"Group 2 innate lymphoid cells exhibit tissue-specific dynamic behaviour during type 2 immune responses","volume":"12","author":"Lok","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0325","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","article-title":"Epithelial cell-derived cytokines: more than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2022.06.005_bb0330","doi-asserted-by":"crossref","first-page":"337ra365","DOI":"10.1126\/scitranslmed.aaf1938","article-title":"Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis","volume":"8","author":"Vannella","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2022.06.005_bb0335","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13071-020-04561-w","article-title":"Interleukin (IL)-33 is dispensable for Schistosoma mansoni worm maturation and the maintenance of egg-induced pathology in intestines of infected mice","volume":"14","author":"Mukendi","year":"2021","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.it.2022.06.005_bb0340","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3389\/fimmu.2019.02827","article-title":"Negative association of interleukin-33 plasma levels and schistosomiasis infection in a site of polyparasitism in rural Cameroon","volume":"10","author":"Kamdem","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0345","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.3389\/fimmu.2018.02781","article-title":"Host regulators of liver fibrosis during human schistosomiasis","volume":"9","author":"Kamdem","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0350","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.4049\/jimmunol.164.10.5337","article-title":"Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-\u03b2 and IL-4","volume":"164","author":"Farah","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0355","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.it.2022.06.005_bb0360","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s00436-015-4492-1","article-title":"Interleukin-33 promotes Th2 immune responses in infected mice with Schistosoma japonicum","volume":"114","author":"Yu","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.it.2022.06.005_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006957","article-title":"Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33","volume":"14","author":"He","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.06.005_bb0370","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3389\/fimmu.2020.01489","article-title":"Helminth sensing at the intestinal epithelial barrier\u2014a taste of things to come","volume":"11","author":"Faniyi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0375","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature16161","article-title":"Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit","volume":"529","author":"von Moltke","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.it.2022.06.005_bb0380","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1126\/science.aaf1648","article-title":"Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut","volume":"351","author":"Howitt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.it.2022.06.005_bb0385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature16527","article-title":"Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites","volume":"529","author":"Gerbe","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.it.2022.06.005_bb0390","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1074-7613(00)80625-1","article-title":"Impaired development of Th2 cells in IL-13-deficient mice","volume":"9","author":"McKenzie","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.it.2022.06.005_bb0395","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-3024.2001.00353.x","article-title":"Stat6 dependent goblet cell hyperplasia during intestinal nematode infection","volume":"23","author":"Khan","year":"2001","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0400","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.4049\/jimmunol.175.5.3207","article-title":"Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection","volume":"175","author":"McDermott","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0405","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-3024.2010.01258.x","article-title":"Changes in the mucosal barrier during acute and chronic Trichuris muris infection","volume":"33","author":"Hasnain","year":"2011","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0410","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biocel.2012.10.011","article-title":"A new role for mucins in immunity: insights from gastrointestinal nematode infection","volume":"45","author":"Hasnain","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.it.2022.06.005_bb0415","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12517","article-title":"A sticky end for gastrointestinal helminths; the role of the mucus barrier","volume":"40","author":"Sharpe","year":"2018","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0420","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.3389\/fimmu.2018.03042","article-title":"Schistosome egg migration: mechanisms, pathogenesis and host immune responses","volume":"9","author":"Costain","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0425","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13071-016-1958-7","article-title":"Efficacy and safety of praziquantel 40 mg\/kg in preschool-aged and school-aged children: a meta-analysis","volume":"10","author":"Zwang","year":"2017","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.it.2022.06.005_bb0430","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1871526519666181231153139","article-title":"PZQ therapy: how close are we in the development of effective alternative anti-schistosomal drugs?","volume":"19","author":"Aruleba","year":"2019","journal-title":"Infect Disord. Drug Targets"},{"key":"10.1016\/j.it.2022.06.005_bb0435","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acsinfecdis.0c00542","article-title":"Alternatives to praziquantel for the prevention and control of schistosomiasis","volume":"7","author":"Spangenberg","year":"2021","journal-title":"ACS Infect Dis."},{"key":"10.1016\/j.it.2022.06.005_bb0440","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fcimb.2017.00443","article-title":"Corilagin counteracts IL-13Ralpha1 signaling pathway in macrophages to mitigate schistosome egg-induced hepatic fibrosis","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.it.2022.06.005_bb0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cea.13491","article-title":"Mechanisms of dupilumab","volume":"50","author":"Harb","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.it.2022.06.005_bb0450","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2019.08.050","article-title":"Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma","volume":"8","author":"Corren","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.it.2022.06.005_bb0455","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.4049\/jimmunol.178.10.6023","article-title":"Cutting edge: IPSE\/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo","volume":"178","author":"Schramm","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0460","doi-asserted-by":"crossref","first-page":"18384","DOI":"10.1074\/jbc.M300497200","article-title":"Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs","volume":"278","author":"Schramm","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2022.06.005_bb0465","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","article-title":"Commentary: IL-4 and IL-13 receptors and signaling","volume":"75","author":"McCormick","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.it.2022.06.005_bb0470","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cyto.2009.07.581","article-title":"Transforming growth factor-beta and Th17 responses in resistance to primary murine Schistosomiasis mansoni","volume":"48","author":"Tallima","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.it.2022.06.005_bb0475","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.intimp.2006.01.021","article-title":"Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis","volume":"6","author":"El Ridi","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.it.2022.06.005_bb0480","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cyto.2006.01.009","article-title":"Influence of interleukin-2 and interferon-gamma in murine schistosomiasis","volume":"33","author":"El Ridi","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.it.2022.06.005_bb0485","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/sji.12399","article-title":"Papain-based vaccination modulates Schistosoma mansoni infection-induced cytokine signals","volume":"83","author":"Abdel Aziz","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0490","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.153.2.753","article-title":"Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis","volume":"153","author":"Cheever","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0495","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4049\/jimmunol.159.2.777","article-title":"IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis","volume":"159","author":"Brunet","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0500","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI7325","article-title":"An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response","volume":"104","author":"Chiaramonte","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2022.06.005_bb0505","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4049\/jimmunol.164.5.2585","article-title":"Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent","volume":"164","author":"Fallon","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.06.005_bb0510","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1084\/jem.20020903","article-title":"Regulation and function of the interleukin 13 receptor \u03b1 2 during a T helper cell type 2-dominant immune response","volume":"197","author":"Chiaramonte","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2022.06.005_bb0515","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4049\/jimmunol.163.1.337","article-title":"Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile","volume":"163","author":"Jankovic","year":"1999","journal-title":"J. Immunol."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490622001211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490622001211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:10:22Z","timestamp":1761462622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490622001211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":103,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1471490622001211"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2022.06.005","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 immunity: a two-edged sword in schistosomiasis immunopathology","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}